Status:
COMPLETED
A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD
Lead Sponsor:
Pfizer
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
35-75 years
Phase:
PHASE1
PHASE2
Brief Summary
A randomised, controlled study investigating the effect of UK-369,003 on exercise tolerance in patients with COPD
Eligibility Criteria
Inclusion
- GOLD criteria 2 to 4
- 10 pack year history of smoking
Exclusion
- Women of child bearing potential
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT00163098
Start Date
December 1 2004
End Date
December 1 2005
Last Update
October 13 2006
Active Locations (28)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Córdoba, Córdoba Province, Argentina, CP 5016
2
Pfizer Investigational Site
San Miguel de Tucumán, Pcia de Tucuman, Argentina, 4000
3
Pfizer Investigational Site
San Miguel de Tucumán, Pcia de Tucuman, Argentina
4
Pfizer Investigational Site
Rosario, Santa Fé, Argentina, 2000